Other languages Anagenics Limited

Equities

AN1

AU0000198095

Market Closed - Australian S.E. Other stock markets 02:10:57 2024-05-27 am EDT			5-day change	1st Jan Change
0.009 ^AUD	0.00%		+28.57%	-52.63%

May. 24	Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics	MT
Mar. 08	Anagenics Appoints CEO	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics	May. 24
Anagenics Appoints CEO	Mar. 07
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 26
Anagenics Completes Placement to Raise AU$1.3 Million	Feb. 06
Anagenics Limited Announces Board Executive Changes	23-10-01
Anagenics Limited completed the acquisition of Face MediGroup.	23-10-01
Anagenics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29
Anagenics Limited Appoints Scott Greasley as Managing Director, Effective from 1 April 2023	23-03-28
Anagenics Limited Announces CEO Changes	23-03-28
Anagenics Limited Appoints Karen Matthews as Non-Executive Director	23-02-13
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-13
Anagenics Limited acquired Uspa Global Pty. Ltd. from BWX Limited.	22-12-08
Anagenics Approves the Election of Mr. Alexander Beard as A Director	22-11-28
Anagenics Limited Announces Resignation of Dennis Eck as Director	22-10-16
Anagenics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-24
Anagenics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-24
Anagenics Limited Appoints Scott Mitchell Greasley as Director	22-07-07
Anagenics Records 121% Jump in Fiscal Q3 Revenue	22-04-28
Anagenics Limited Appoints Matthew Dudek as Acting Chief Executive Officer, Effective 28 February 2022	22-02-28
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Anagenics Limited

Equities

AN1

AU0000198095

Other languages

Filters